Product Images Bexagliflozin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Bexagliflozin NDC 82381-2000 by Theracosbio, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bexagliflozin-label-30s - bexagliflozin 20 mg 30 tablets

bexagliflozin-label-30s - bexagliflozin 20 mg 30 tablets

This is a description of Bexagliflozin Tablets 20 mg. The tablets contain Bexagliflozin 20 mg and should not be accepted if the bottle seal is broken or missing. They should be stored at a temperature between 20°C to 25°C (68°F to 77°F). It is advised not to crush or chew the tablets. Each bottle contains 30 tablets and should be dispensed with the enclosed Medication Guide to each patient. Distributed by TheracosBio, LLC based in Marlborough, MA, the tablets are for prescription use only. The NDC number is 82381-2000-8.*

bexagliflozin-label-90s - bexagliflozin 20 mg 90 tablets

bexagliflozin-label-90s - bexagliflozin 20 mg 90 tablets

This is a description for Bexagliflozin tablets with 20 mg dosage. Each tablet contains bexagliflozin. The tablets should not be accepted if the bottle seal is broken or missing. They should be kept out of reach of children and stored at 20 to 25 degrees Celsius. The tablets should not be crushed or chewed. Dosage information can be found in the prescribing medication guide. The product is distributed by a specific pharmaceutical company.*

bexagliflozin-figure-1 - bexagliflozin figure 1

bexagliflozin-figure-1 - bexagliflozin figure 1

bexagliflozin-figure-2 - bexagliflozin figure 2

bexagliflozin-figure-2 - bexagliflozin figure 2

The text provides information on the pharmacokinetic parameters (AUC and Cmax) of Metformin, Glimepiride, Stagliptin, and Digoxin at certain doses. It also mentions the Geometric Mean Ratio with 90% confidence intervals for comparison purposes. This data may be part of a clinical study or drug interaction analysis.*

bexagliflozin-figure-3 - bexagliflozin figure 3

bexagliflozin-figure-3 - bexagliflozin figure 3

This information appears to be a comparison between the drug "BRENZAVVY" and a placebo. The data seems to show the measured values of Bex and Pbo over a span of 24 weeks. The values for Bex appear to decrease from 138 to 124, while the values for Pbo decrease from 69 to 64 and then back to 69. The trend of the two substances over the duration of the study could indicate the efficacy of the drug compared to the placebo.*

bexagliflozin-structure - bexagliflozin structure

bexagliflozin-structure - bexagliflozin structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.